Literature DB >> 26117931

MANAGEMENT OF DIABETIC RETINOPATHY, PREVALENCE AND CLINICAL CLASSIFICATION.

Alil Ajvazi, Pajtim Lutaj, Ilhami Goranci.   

Abstract

AIMS: To ascertain the prevalence of diabetic retinopathy--DR, based on the duration of the diabetes mellitus--DM and to compare it with data from relevant literature and other referent clinics.
MATERIAL AND METHODS: In this study are included the patients with diabetes mellitus type 1 insulin-dependent--DMID and diabetes mellitus type 2 non-insulin-dependent--DMNID. The duration of diabetes in the examined patients varied from 5 till 30 years. We have applied examination by ophthalmoscope, slit lamp bio-microscopy with Volk and Goldman lens, optical coherence tomography--OCT as well as fluorescein angiography--FAG. Have been included the treated patients with DR, from September 2004-2014.
RESULTS: In diabetic patients suffering for a period of 5 years, the prevalence of DR is 10%. In diabetic patients suffering over 30 years, the prevalence of DR is varied from 82% until 97%.
CONCLUSION: Diabetic retinopathy, undertakes a multidisciplinary approach in all patients with diabetes to achieve optimal blood glucose control HbA1c levels 7.0% or lower and to adequately manage systolic blood pressure less than 140 mmHg and serum LDL cholesterol of less than 2.5 mmol/L and triglycerides of less than 2.0 mmol/L. Always should be assessed visual acuity at the time of DR examination.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 26117931

Source DB:  PubMed          Journal:  Oftalmologia        ISSN: 1220-0875


  2 in total

1.  CLINICAL IMPACT IN THE MANAGEMENT OF NEOVASCULAR GLAUCOMA.

Authors:  Halil Ajvazi; Pajtim Lutaj
Journal:  Rom J Ophthalmol       Date:  2015 Jul-Sep

2.  Multimodal Imaging Assessment of Vascular and Neurodegenerative Retinal Alterations in Type 1 Diabetic Patients without Fundoscopic Signs of Diabetic Retinopathy.

Authors:  Riccardo Sacconi; Marco Casaluci; Enrico Borrelli; Giacomo Mulinacci; Francesca Lamanna; Francesco Gelormini; Adriano Carnevali; Lea Querques; Gianpaolo Zerbini; Francesco Bandello; Giuseppe Querques
Journal:  J Clin Med       Date:  2019-09-08       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.